Eisai will maintain the rights to tasurgratinib worldwide outside of the licensed regions.

Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from manageable conditions to fatal diseases.

Beyond research, Germain concludes the conversation by providing helpful insights into the biggest challenges in lymphoma ...

Slow the Spread. In the mouse brain, phospho-synuclein pathology (green) accumulates (top) in, from left to right, the motor ...

This useful study presents findings on the developmental roles of Nup107, a key nucleoporin, in regulating the larval-to-pupal transition in Drosophila melanogaster through its involvement in ecdysone ...

SciClone will develop and distribute Tasfygo in greater China but Eisai will retain worldwide rights outside the region.

L-tyrosine is an amino acid that's often used in supplements to improve cognitive function affected by stress. Supplements containing L-tyrosine supplements may also help treat phenylketonuria (PKU).

Hematopoietic and lymphocytic neoplasms (HLNs) are a diverse group of malignancies affecting blood and lymphatic systems, with outcomes varying from ...

Needham & Company LLC reaffirmed their hold rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a research report report published on Wednesday,Benzinga reports. A number of other ...

Protein kinase inhibitors represent a major advance in cancer treatment due to their ability to target the specific kinases involved in tumor growth and survival. More than 80 small-molecule ...

TERN-701 CARDINAL study progressing well; dose expansion expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25New ...